masshealth glp 1 coverage GLP-1 change: State board drops of obesity drugs Designing fiscally viable coverage of

The mean age in the matched cohorts was 52.4 years, with the population comprising 55.6% females and 61% Whites

There are only two GLP-1 agonists that are TGA approved for weight loss, semaglutide (Wegovy brand) and liraglutide (Saxenda)

Dosing and Administration Currently orally administered semaglutide is approved by the US Food and Drug Administration (FDA), European Medicines Agency, Health Canada, Australia and Japan as an adjunct to diet and exercise to improve glycaemic control in adults with T2DM

When weight comes off quicklyespecially without adequate protein and strength trainingmuscle mass can decline right alongside fat, undermining long-term health and metabolic resilience

A systematic review with meta-analysis on 33 data sets with at least 10 years follow up, including a single center with 20 years of follow-up, found significant and sustained weight loss after surgery

And the vanquished treatments were a little toasty